R0L.F J Frontier Co.,Ltd.
- Market cap
- EUR 55.5M
- P/E
- -
- P/B
- 8.18x
- ROE
- -3.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Aug 2026.
Is R0L.F undervalued?
Graham numberThe Graham number of J Frontier Co.,Ltd. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
J Frontier Co.,Ltd. fundamental analysis
No fundamental analysis for J Frontier Co.,Ltd. yet.
J Frontier Co.,Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About J Frontier Co.,Ltd.
J Frontier Co.,Ltd. engages in the healthcare sales, medical care sales, and healthcare marketing businesses in Japan. It operates SOKUYAKU, one-stop service platform that provides online medical consultations, medication guidance, prescription drug delivery, and digital transformation support for medical institutions. The company also sells health, beauty, education, healing, medicine, and healthcare products, as well as health food through mail order; and provides product …
Full company profileJ Frontier Co.,Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Aug 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
J Frontier Co.,Ltd. annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 11.9B | 16.8B | 17.7B | 21.5B | 22.2B | 23.6B |
| Gross Profit | 5.40B | 7.12B | 8.33B | 9.57B | 8.98B | 9.96B |
| Operating Income | 731M | -1.82B | -605M | 294M | 312M | 336M |
| EBITDA | - | -1.54B | -1.23B | 571M | 355M | 346M |
| Net Income | 401M | -1.90B | -2.10B | 87.6M | -321M | -40.9M |
| EPS | 88 | -405 | -424 | 17 | -60 | -7.66 |
| Balance Sheet | ||||||
| Total Assets | 6.10B | 7.24B | 11.4B | 9.17B | 9.59B | 9.59B |
| Total Liabilities | 1.94B | 4.53B | 9.53B | 7.16B | 8.05B | 8.10B |
| Shareholders' Equity | 4.14B | 2.48B | 1.14B | 1.41B | 1.23B | 1.20B |
| Cash & Short-term Investments | 2.96B | 1.65B | 1.81B | 2.17B | 2.16B | 2.03B |
| Cash Flow | ||||||
| Operating Cash Flow | -367M | -1.83B | -1.44B | 509M | 454M | - |
| Capital Expenditure | 10.5M | 105M | 109M | 61.8M | 69.0M | 0.00 |
| Free Cash Flow | -377M | -1.94B | -1.54B | 447M | 385M | - |
| Ratios | ||||||
| ROE | 9.7% | -76.7% | -184.4% | 6.2% | -26.2% | -3.4% |
| ROA | 6.6% | -26.2% | -18.4% | 1.0% | -3.4% | -0.4% |
| Net Profit Margin | 3.4% | -11.3% | -11.9% | 0.4% | -1.4% | -0.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
J Frontier Co.,Ltd. dividends
J Frontier Co.,Ltd. has not paid dividends in the last 5 fiscal years.
Who owns J Frontier Co.,Ltd.
- Insiders 78.39%
- Institutions 1.43%
- Public & others 20.18%
- Shares outstanding 5.34M
- Free float 1.26M
J Frontier Co.,Ltd. company profile
- Company name
- J Frontier Co.,Ltd.
- Ticker
- R0L.F
- ISIN
- JP3386650000
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Employees
- 201
- Fiscal year end
- May
- Address
- 9-8 Sakuragaokacho, Shibuya, Japan, 150-0031
- Phone
- 81 3 6427 4662
- Website
- jfrontier.jp
About J Frontier Co.,Ltd.
J Frontier Co.,Ltd. engages in the healthcare sales, medical care sales, and healthcare marketing businesses in Japan. It operates SOKUYAKU, one-stop service platform that provides online medical consultations, medication guidance, prescription drug delivery, and digital transformation support for medical institutions. The company also sells health, beauty, education, healing, medicine, and healthcare products, as well as health food through mail order; and provides product sales promotion support services. In addition, it offers internet advertising for healthcare-related companies. J Frontier Co.,Ltd. was incorporated in 2008 and is based in Shibuya, Japan.
J Frontier Co.,Ltd. management
5- Mr. Yuya HiguchiChairman of the Board, Exe. Officer, CFO and Head of Corp. Planning Headquarters & Corp. Division · born 1984
- Mr. Atsuhiro NakamuraPresident, CEO & Representative Director · born 1980
- Mr. Nana FukazawaExecutive Officer & Head of SOKUYAKU Business Division
- Yuji IiExecutive Officer, GM of Corporate Plan. Dep. and Head of Acc. & Finance Department of Corporate HQ
- Katsutoshi MinagawaExecutive Officer of Corporate Planning Department